title: [The effect of the succinic acid preparation on the dynamics of neurological and emotional disturbances in patients with dorsopathy].
abstract: OBJECTIVE
  To study the dynamics of neurological and emotional disturbances in patients with dorsopathy treated with cytoflavin.
  
  
  METHODS
  We examined 120 patients aged from 21 to 55 years, mean age 38±9 years. All patients received nonsteroid anti-inflammatory drugs, myorelaxants, vitamins. The main group comprised 67 patients who received cytoflavin (10ml of the solution in one injection once a day in 200 ml of isotonic solution of sodium chloride intravenously in drops in the morning during 10 days) in addition to standard treatment. The comparison group included 53 patients who received standard treatment during 10 days.
  
  
  CONCLUSIONS
  The use of cytoflavin allowed earlier arresting of the pain syndrome, restored the disturbed sensitivity, improved emotional status and decreased the severity of a neuropathic pain component.
authors.affiliation: Razumovsky Saratov State Medical University, Saratov.
authors.forename: Ya A
authors.initials: YA
authors.lastname: Stetsura
authors.affiliation: Razumovsky Saratov State Medical University, Saratov.
authors.forename: I I
authors.initials: II
authors.lastname: Sholomov
authors.affiliation: Razumovsky Saratov State Medical University, Saratov.
authors.forename: N V
authors.initials: NV
authors.lastname: Schukovsky
authors.affiliation: Razumovsky Saratov State Medical University, Saratov.
authors.forename: E A
authors.initials: EA
authors.lastname: Salina
authors.affiliation: Razumovsky Saratov State Medical University, Saratov.
authors.forename: E B
authors.initials: EB
authors.lastname: Likhacheva
mesh_terms: D000328:Adult; D000342:Affective Symptoms / Q000175:diagnosis* / Q000209:etiology; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D004338:Drug Combinations; D005260:Female; D005486:Flavin Mononucleotide / Q000627:therapeutic use*; D006801:Humans; D007290:Inosine Diphosphate / Q000627:therapeutic use*; D017116:Low Back Pain / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D009465:Neuromuscular Agents / Q000627:therapeutic use; D009536:Niacinamide / Q000627:therapeutic use*; D013386:Succinates / Q000627:therapeutic use*; D019802:Succinic Acid / Q000627:therapeutic use*; D055815:Young Adult
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D004338:Drug Combinations; D009465:Neuromuscular Agents; D013386:Succinates; C507879:cytoflavin; D009536:Niacinamide; D005486:Flavin Mononucleotide; D007290:Inosine Diphosphate; D019802:Succinic Acid